Peripheral T-lymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation Full Text
BMC Cancer,

Ochoa-Hernandez AB et al. – To the knowledge of the authors, this is the first report evidencing quantitatively decreased WNT7A levels in leukemia-derived cells and that WNT7A restoration in T-lymphocytes inhibits cell proliferation. These results also support the possible function of WNT7A as a tumor suppressor gene as well as a therapeutic tool.

Methods

  • Analyzed peripheral blood mononuclear cells, sorted CD3 and CD19 cells, 4 leukemia-derived cell lines, and blood samples from 14 patients with Acute lymphoblastic leukemia (ALL), and 19 clinically healthy subjects
  • Reverse transcription followed by quantitative Real-time Polymerase chain reaction (qRT-PCR) analysis were performed to determine relative WNT7A expression
  • Restoration of WNT7a was done employing a lentiviral system and by using a recombinant human protein
  • Cell proliferation was measured by addition of WST-1 to cell cultures

Results
  • WNT7a is mainly produced by CD3 T-lymphocytes, its expression decreases upon activation, and it is severely reduced in leukemia-derived cell lines, as well as in the blood samples of patients with ALL when compared with healthy controls (p [less than or equal to]0.001)
  • By restoring WNT7A expression in leukemia-derived cells, we were able to demonstrate that WNT7a inhibits cell growth
  • Similar effect was observed when a recombinant human WNT7a protein was used
  • Restoration of WNT7A expression in Jurkat cells did not activate the canonical Wnt/beta-catenin pathway

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore